231 related articles for article (PubMed ID: 33376721)
1. Natural Products: Review for Their Effects of Anti-HBV.
Liu X; Ma C; Liu Z; Kang W
Biomed Res Int; 2020; 2020():3972390. PubMed ID: 33376721
[TBL] [Abstract][Full Text] [Related]
2. Naturally derived anti-hepatitis B virus agents and their mechanism of action.
Wu YH
World J Gastroenterol; 2016 Jan; 22(1):188-204. PubMed ID: 26755870
[TBL] [Abstract][Full Text] [Related]
3. Potential Drug Targets Against Hepatitis B Virus Based on Both Virus and Host Factors.
Zhang BY; Chai DP; Wu YH; Qiu LP; Zhang YY; Ye ZH; Yu XP
Curr Drug Targets; 2019; 20(16):1636-1651. PubMed ID: 31362671
[TBL] [Abstract][Full Text] [Related]
4. A review of non-nucleoside anti-hepatitis B virus agents.
Zhang F; Wang G
Eur J Med Chem; 2014 Mar; 75():267-81. PubMed ID: 24549242
[TBL] [Abstract][Full Text] [Related]
5. Anti-hepatitis B virus activities of natural products and their antiviral mechanisms.
Deng W; Chen F; Zhao Y; Zhou M; Guo M
Chin J Nat Med; 2023 Nov; 21(11):803-811. PubMed ID: 38035936
[TBL] [Abstract][Full Text] [Related]
6. Past, Current, and Future Developments of Therapeutic Agents for Treatment of Chronic Hepatitis B Virus Infection.
Pei Y; Wang C; Yan SF; Liu G
J Med Chem; 2017 Aug; 60(15):6461-6479. PubMed ID: 28383274
[TBL] [Abstract][Full Text] [Related]
7. Antiviral Natural Products Against Chronic Hepatitis B: Recent Developments.
Parvez MK; Arbab AH; Al-Dosari MS; Al-Rehaily AJ
Curr Pharm Des; 2016; 22(3):286-93. PubMed ID: 26561057
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of metachromin A on hepatitis B virus production via impairment of the viral promoter activity.
Yamashita A; Tamaki M; Kasai H; Tanaka T; Otoguro T; Ryo A; Maekawa S; Enomoto N; de Voogd NJ; Tanaka J; Moriishi K
Antiviral Res; 2017 Sep; 145():136-145. PubMed ID: 28827084
[TBL] [Abstract][Full Text] [Related]
9. Naturally occurring and synthetic bioactive molecules as novel non-nucleoside HBV inhibitors.
Zhan P; Jiang X; Liu X
Mini Rev Med Chem; 2010 Feb; 10(2):162-71. PubMed ID: 20408799
[TBL] [Abstract][Full Text] [Related]
10. Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs.
Huang H; Zhou W; Zhu H; Zhou P; Shi X
Toxicol Appl Pharmacol; 2017 May; 323():36-43. PubMed ID: 28322895
[TBL] [Abstract][Full Text] [Related]
11. Recent advance of the hepatitis B virus inhibitors: a medicinal chemistry overview.
Jia H; Rai D; Zhan P; Chen X; Jiang X; Liu X
Future Med Chem; 2015; 7(5):587-607. PubMed ID: 25921400
[TBL] [Abstract][Full Text] [Related]
12. Anti-HBV agents derived from botanical origin.
Qiu LP; Chen KP
Fitoterapia; 2013 Jan; 84():140-57. PubMed ID: 23164603
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Biological Evaluation of Matijin-Su Derivatives as Potential Antihepatitis B Virus and Anticancer Agents.
Qiu J; Xu B; Gong Q; Pan W; Liu C; Huang Z; Gu X; Liang G
Chem Biodivers; 2016 Nov; 13(11):1584-1592. PubMed ID: 27451105
[TBL] [Abstract][Full Text] [Related]
14. An Effective Antiviral Approach Targeting Hepatitis B Virus with NJK14047, a Novel and Selective Biphenyl Amide p38 Mitogen-Activated Protein Kinase Inhibitor.
Kim SY; Kim H; Kim SW; Lee NR; Yi CM; Heo J; Kim BJ; Kim NJ; Inn KS
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559272
[TBL] [Abstract][Full Text] [Related]
15. An overview of anti-Hepatitis B virus flavonoids and their mechanisms of action.
Naderi M; Salavatiha Z; Gogoi U; Mohebbi A
Front Cell Infect Microbiol; 2024; 14():1356003. PubMed ID: 38487354
[TBL] [Abstract][Full Text] [Related]
16. Anti-HBV Drugs: Progress, Unmet Needs, and New Hope.
Kang L; Pan J; Wu J; Hu J; Sun Q; Tang J
Viruses; 2015 Sep; 7(9):4960-77. PubMed ID: 26389937
[TBL] [Abstract][Full Text] [Related]
17. Variability in the Responses of Hepatitis B Virus D-Subgenotypes to Antiviral Therapy: Designing Pan-D-Subgenotypic Reverse Transcriptase Inhibitors.
Khatun M; Kumar K; Baidya A; Mondal RK; Baszczyňski O; Kalčic F; Banerjee S; Dhali GK; Das K; Chowdhury A; Janeba Z; Chakrabarti S; Datta S
J Virol; 2022 Jan; 96(2):e0180021. PubMed ID: 34730399
[TBL] [Abstract][Full Text] [Related]
18. Update on hepatitis B virus infection.
You CR; Lee SW; Jang JW; Yoon SK
World J Gastroenterol; 2014 Oct; 20(37):13293-305. PubMed ID: 25309066
[TBL] [Abstract][Full Text] [Related]
19. Antiviral activity of a polysaccharide from Radix Isatidis (Isatis indigotica Fortune) against hepatitis B virus (HBV) in vitro via activation of JAK/STAT signal pathway.
Wang T; Wang X; Zhuo Y; Si C; Yang L; Meng L; Zhu B
J Ethnopharmacol; 2020 Jul; 257():112782. PubMed ID: 32217096
[TBL] [Abstract][Full Text] [Related]
20. Small-molecule inhibitors for the treatment of hepatitis B virus documented in patents.
Geng CA; Wang LJ; Guo RH; Chen JJ
Mini Rev Med Chem; 2013 Apr; 13(5):749-76. PubMed ID: 23317498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
